SCHEDULE: Vanguard Group Reports Zero Hims & Hers Stake Post-Realignment

The Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership in Hims & Hers Health Inc. following an internal corporate realignment.

Summary

• The Vanguard Group filed an Amendment No. 5 to its Schedule 13G for Hims & Hers Health Inc. Common Stock.
• The filing indicates that The Vanguard Group now beneficially owns 0 shares, representing 0% of the Common Stock of Hims & Hers Health Inc.
• This change is attributed to an internal realignment within The Vanguard Group, Inc., which became effective on January 12, 2026.
• Following the realignment, certain subsidiaries and business divisions of The Vanguard Group, Inc. will now report their beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538 (January 12, 1998).
• These disaggregated entities continue to pursue the same investment strategies as previously pursued by The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for Hims & Hers, as it primarily reflects an internal reporting change by The Vanguard Group rather than a change in investment thesis or performance of the issuer.

Positives

• The Vanguard Group is maintaining transparency by updating its beneficial ownership status in accordance with regulatory requirements.
• The internal realignment and disaggregated reporting may offer more granular insights into specific fund holdings by Vanguard-affiliated entities in the future.

Negatives

• The Vanguard Group, as the parent entity, no longer reports direct beneficial ownership in Hims & Hers Health Inc., which could be misinterpreted as a complete divestment by all Vanguard-affiliated funds if the context of the reporting change is not fully understood.

Risks

• The change in reporting structure could lead to initial confusion among investors regarding the actual aggregate institutional ownership by Vanguard-affiliated entities in Hims & Hers Health Inc.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Hims & Hers Health Inc.'s business or financial performance. It solely addresses a change in The Vanguard Group's beneficial ownership reporting structure.

Management Comments

• "On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment."
• "Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release."
• "The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions."

Industry Context

StockSavvy.ai notes that this filing reflects a common practice among large institutional investors like The Vanguard Group to adjust their internal reporting structures for beneficial ownership, often driven by regulatory interpretations or internal operational efficiencies. While it shows a 0% direct stake for the parent entity, it does not necessarily imply a complete divestment by all Vanguard-affiliated funds, as these holdings are now reported separately.

Comparison to Industry Standards

• This realignment and disaggregated reporting by a major asset manager like The Vanguard Group aligns with industry best practices for transparency and compliance with SEC regulations, specifically referencing SEC Release No. 34-39538.
• Similar reporting adjustments have been observed with other large fund complexes, such as BlackRock or State Street, when they restructure internal investment divisions or interpret beneficial ownership rules for their diverse fund offerings.

Stakeholder Impact

• Shareholders (Hims & Hers): May initially perceive a reduction in institutional ownership by Vanguard, but the underlying holdings by Vanguard-affiliated funds likely remain, just reported differently. Requires careful interpretation to avoid misjudgment.
• Regulators (SEC): The filing demonstrates compliance with reporting requirements following an internal restructuring.

Next Steps

• Individual Vanguard subsidiaries or business divisions will now report their beneficial ownership in Hims & Hers Health Inc. separately in future filings.

Key Dates

Recommendation

This filing is a technical amendment by The Vanguard Group regarding its internal reporting structure and does not reflect a change in the investment fundamentals or outlook for Hims & Hers Health Inc. Therefore, it provides no basis for a change in investment recommendation for Hims & Hers. Investors should hold their position and monitor company-specific news.

Keywords

Hims & Hers Health Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Ownership, Corporate Realignment, Common Stock, Investment Management